GW&K Investment Management, LLC

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1082917 BOSTON, MA

Back to TEVA Full portfolio

Position in TEVA

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$7,831

+$2,182 QoQ

Shares Held

260

+43.6% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

GW&K Investment Management, LLC holds $163,730,959 across 8 Drug Manufacturers - Specialty & Generic names. TEVA ranks #8 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	593,725	$78,217,331
2	SUPN	Supernus Pharmaceuticals, Inc.	1,055,184	$54,542,460
3	BCRX	Biocryst Pharmaceuticals Inc	3,240,462	$30,849,197
4	VTRS	Viatris Inc	2,967	$40,084
5	HLN	Haleon plc	3,869	$38,728
6	ZTS	Zoetis Inc.	208	$24,587
7	TAK	Takeda Pharmaceutical Co Ltd	580	$10,741
8	TEVA	Teva Pharmaceutical Industries Ltd This page	260	$7,831

All Filings in TEVA

Export CSV

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$7,831	260	+43.6%	Shares	Sole	2026-05-13
2025-12-31	$5,649	181	0.0%	Shares	Sole	2026-02-11
2025-09-30	$3,656	181	0.0%	Shares	Sole	2025-11-12
2025-06-30	$3,033	181	0.0%	Shares	Sole	2025-08-11
2025-03-31	$2,781	181	0.0%	Shares	Sole	2025-05-05
2024-12-31	$3,989	181	0.0%	Shares	Sole	2025-02-05
2024-09-30	$3,261	181	+26.6%	Shares	Sole	2024-11-07
2024-06-30	$2,323	143	0.0%	Shares	Sole	2024-08-12
2024-03-31	$2,017	143	0.0%	Shares	Sole	2024-05-08
2023-12-31	$1,492	143	0.0%	Shares	Sole	2024-02-09
2023-09-30	$1,458	143	0.0%	Shares	Sole	2023-11-09
2023-06-30	$1,076	143	—	Shares	Sole	2023-08-09
No filing history on record for this holder in this stock.